Urinary survivin test compared to the nuclear matrix protein (NMP)-22 test and urine cytology for the diagnosis of bladder cancer

Korean Journal of Urology

Volumn 47, Issue 10, 2006, Pages 1041-1045

  Chang, Sang Hoon ^a   Kim, Young Ho ^a   Kim, Min Eui ^a  

^a Department of Urology   (South Korea)

Author keywords

Bladder cancer; Cytology; Nuclear matrix protein 22; Survivin; Urine

Indexed keywords

NUCLEAR MATRIX PROTEIN 22; SURVIVIN;

ANALYTICAL EQUIPMENT; ARTICLE; AUTOANALYSIS; BLADDER CANCER; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; PATIENT IDENTIFICATION; RELIABILITY; SENSITIVITY AND SPECIFICITY; SUPERFICIAL CANCER; URINALYSIS; URINE CYTOLOGY;

EID: 33751357384     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.10.1041     Document Type: Article

References (18)

1. Kwon DH, Hong SJ. The clinical utility of BTA TRAK, BTA stat, NMP22 and urine cytology in the diagnosis of bladder cancer: a comparative study. Korean J Urol 2003;44:721-6
2. Park JO, Moon DG, Cheon J, Kim JJ, Yoon DK. Urinary NMP (nuclear matrix protein) 22 in screening and post-treatment follow-up bladder cancer. Korean J Urol 1999;40:551-6
3. Shariat SF, Casella R, Khoddami SM, Hernandez G, Sulser T, Gasser TC, et al. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 2004;171:626-30
4. Kim JM, Lee KW, Kim YH, Park SK, Lee YK, Kim ME. Expression of urinary survivin as a new tumor marker for the detection of bladder cancer. Korean J Urol 2004;45:1219-23
5. Fuessel S, Kueppers B, Ning S, Kotzsch M, Kraemer K, Schmidt U, et al. Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cells. J Urol 2004;171:2471-6
6. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396:580-4
7. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, et al. Analysis of human transcriptomes. Nature Genet 1999;23:387-8
8. Konno R, Yamakawa H, Utsunomiya H, Ito K, Sato S, Yajima A. Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod 2000;6:529-34
9. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21
10. Swana HA, Grossman D, Anthony JN, Weiss RM, Altieri DC. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 1999;341:452-3
11. Hausladen DA, Wheeler MA, Altieri DC, Colberg JW, Weiss RM. Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome. J Urol 2003;170:230-4
12. Ku JH, Kwak C, Lee HS, Park HK, Lee ES, Lee SE. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol 2004;171:631-5
13. Garcia I, Martinou I, Tsujimoto Y, Martinou JC. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 1992;258:302-4
14. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998;58:5315-20
15. Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC. Urine detection of survivin and diagnosis of bladder cancer. JAMA 2001;285:324-8
16. Schultz IJ, Kiemeney LA, Witjes JA, Schalken JA, Willems JL, Swinkels DW, et al. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res 2003;23:3327-31
17. Miller TE, Beausang LA, Winchell LF, Lidgard GP. Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res 1992;52:422-7
18. Keesee SK, Briggman JV, Thill G, Wu YJ. Utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gene Expr 1996;6:189-214